Nevertheless, recent data showed that booster MMR vaccine in patients with juvenile idiopathic arthritis receiving bDMARDs (anti-TNFα, anti-IL-1, or anti-IL-6) is safe and immunogenic, with no patients developing a disease flare [6, 7]. This evidence concerns the gene IL6 and juvenile idiopathic arthritis.